Neurotrophins and target interactions in the development and regulation of sympathetic neuron electrical and synaptic properties.
The electrical and synaptic properties of neurons are essential for determining the function of the nervous system. Thus, understanding the mechanisms that control the appropriate developmental acquisition and maintenance of these properties is a critical problem in neuroscience. A great deal of our understanding of these developmental mechanisms comes from studies of soluble growth factor signaling between cells in the peripheral nervous system. The sympathetic nervous system has provided a model for studying the role of these factors both in early development and in the establishment of mature properties. In particular, neurotrophins produced by the targets of sympathetic innervation regulate the synaptic and electrophysiological properties of postnatal sympathetic neurons. In this review we examine the role of neurotrophin signaling in the regulation of synaptic strength, neurotransmitter phenotype, voltage-gated currents and repetitive firing properties of sympathetic neurons. Together, these properties determine the level of sympathetic drive to target organs such as the heart. Changes in this sympathetic drive, which may be linked to dysfunctions in neurotrophin signaling, are associated with devastating diseases such as high blood pressure, arrhythmias and heart attack. Neurotrophins appear to play similar roles in modulating the synaptic and electrical properties of other peripheral and central neuronal systems, suggesting that information provided from studies in the sympathetic nervous system will be widely applicable for understanding the neurotrophic regulation of neuronal function in other systems.
Luther
Jason A
JA
Department of Biology, National Center for Behavioral Genomics, Brandeis University, Waltham, MA 02454, USA. jluther@brandeis.edu
Birren
Susan J
SJ
D000200:Action Potentials / Q000502:physiology; D000320:Adrenergic Fibers / Q000502:physiology; D000818:Animals; D001342:Autonomic Nervous System Diseases / Q000503:physiopathology; D002799:Cholinergic Fibers / Q000502:physiology; D005728:Ganglia, Sympathetic / Q000166:cytology / Q000502:physiology; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology; D009414:Nerve Growth Factors / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000502:physiology; D009473:Neuronal Plasticity / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000502:physiology*; D010766:Phosphorylation; D011188:Potassium / Q000502:physiology; D015221:Potassium Channels / Q000502:physiology; D011499:Protein Processing, Post-Translational; D020800:Receptor, Nerve Growth Factor / Q000502:physiology; D020917:Receptor, trkA / Q000502:physiology; D013564:Sympathetic Nervous System / Q000166:cytology / Q000196:embryology / Q000254:growth & development* / Q000502:physiology; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology*
D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D015221:Potassium Channels; D020800:Receptor, Nerve Growth Factor; D020917:Receptor, trkA; D011188:Potassium